by Jim Tate | Nov 30, 2017 | MIPS
Earlier this week I published a post entitled MIPS: The Day of Reckoning. That screed covered my thoughts on the predictability and inevitability of the impact of the first MIPS scores being publicly released in 2018. I will not bore you with how important those...
by Jim Tate | Nov 28, 2017 | MIPS
One of my favorite books is The Big Short by Michael Lewis. It was eventually made into a movie by the same name and gives a clear view of the housing bubble that burst 10 years ago and pushed the US economy into the Great Recession. What fascinates me was the ability...
by Jim Tate | Nov 9, 2017 | MIPS
This morning when I googled “MIPS timeline” I got 174,000 results. There sure are lots of pretty charts and colorful graphs out there. Most of them will let you know when this will happen and when that will occur. When does the definition of Eligible Clinicians...
by Jim Tate | Nov 6, 2017 | MIPS
Several weeks ago I wrote a post entitled “MIPS and Medicare Part B Drugs – Waiting for the Other Shoe to Drop”. Late last week the other shoe hit the floor with the release of the Final Rule. The issue at hand is whether an Eligible Clinician’s (EC) MIPS score would...